Inborn errors of immunity (IEI) are genetic disorders that not only heighten infection risk but also disrupt immune regulation, frequently leading to lymphoid tissue overgrowth known as lymphoid proliferations (LPD). We retrospectively reviewed 38 patients with genetically or clinically confirmed IEI and persistent LPD, comparing those with nonneoplastic/reactive hyperplasia to those who developed overt lymphoid neoplasm (lymphoma). Overall, 26% developed lymphoma—predominantly classical Hodgkin lymphoma or diffuse large B cell lymphoma—often after earlier IEI onset. Immunophenotyping and principal component analysis revealed that patients with common variable immunodeficiency developing Hodgkin lymphoma shared a distinctive T cell profile, differing from immunocompetent lymphoma cases. Centralized histologic re-evaluation reclassified several presumed lymphoma as nonneoplastic/reactive hyperplasia and identified Castleman-like and germinal center transformation patterns in nonneoplastic/reactive LPD. Notably, elevated blood IgM and circulating T follicular helper cells mirrored IgM deposits and PD-1+ T cells in lymph nodes. These findings highlight the importance of an integrated approach involving clinical, genetic, and pathological reviews to improve IEI diagnosis and avoid overtreatment.
30 November 2022 in Pediatric and Developmental Pathology
Secretory carcinoma (SC) is a salivary gland tumor with a generally low grade microscopic appearance, a characteristic immunophenotype, and a recurrent translocation leading to ETV6::NTRK3 fusion gene. Rare cases are reported in children. The maxillary sinus is an unusual localization. SC have an overall favorable prognosis, but cases with high grade morphology have been described in adult population and are related to a more aggressive clinical course. We present a pediatric case of secretory carcinoma involving the maxillary sinus with high grade morphology, with a review of the literature of secretory carcinomas with high grade component.
Patients with thymoma are more susceptible to develop infections due to possible autoimmune impairment due to autoantibodies directed towards cytokines involved in immune response, and this could play a role also in syndrome coronavirus type 2 (SARS-CoV-2) infection. We report on two cases of thymoma incidentally diagnosed in patients affected by SARS-CoV-2 infection, in one case the patient had a severe SARS-CoV-2-related pneumonia, in the second case only a mild SARS-CoV-2 infection was detected. Case No.1 was a 57 years old man with a recent history of severe SARS-CoV-2 related pneumonia, inducing treatment with corticosteroids. Imaging studies revealed the presence of an anterior mediastinal mass. Case No.2 was a 44 years old woman, with a recent history of mild SARS-CoV-2 infection treated with a domicile therapy including corticosteroids and paracetamol. Imaging studies revealed a mediastinal para-cardiac mass. In both cases the tumors were completely removed. Case No.1: after mass removal and histological examination, we made a diagnosis of B3 thymoma with a component of B2, pT3, pN0. Case No.2: after removal of the mass, the diagnosis of thymoma B2 with a minor component B3, pT1a, pNx was made. SARS-CoV-2 infection has represented the opportunity to discover the disease, because the patients were otherwise asymptomatic for the neoplasia. In both cases the patients were treated with corticosteroids. The treatment could lead to histological modifications including lymphocyte depletion, that could bring to overestimate the epithelial neoplastic component and to overdiagnoses B3 areas in an otherwise B2 thymoma. Recent studies have demonstrated that neoplastic thymic epithelial cells have significative increase of expression of cathepsin L (CTSL), one of the proteins known to be mediators and facilitators for the viral infection. Anyway, the possibility of a direct infection of the neoplastic cells by the virus has not been demonstrated and requires further studies.
Cleft palate is a congenital anomaly that causes functional and esthetic challenges, and the hard palate is essential for feeding, speech, and separation of the oral and nasal cavities. Yet, current reconstructive techniques do not restore its bony component. Building on previous in vitro work showing that decellularized palatal mucoperiosteum, microperforated with Quantum Molecular Resonance (QMR®) technology and recellularized with mesenchymal stem cells, preserves the collagen microenvironment, supports engraftment, and shows osteoinductive potential, this study evaluated the early feasibility and regenerative potential of bioengineered mucoperiosteal scaffolds (BEMS) in Landrace pigs model. Bone marrow was collected from recipient pigs to isolate pBM-MSCs. Donor palatal mucoperiosteum was decellularized, microperforated, and recellularized with these cells to generate BEMS. After surgical creation of a cleft palate, four pigs received BEMS, and two controls underwent standard palatoplasty. At one month, scaffold-treated animals showed early mucosal and osseous regeneration, including neo-epithelium, connective tissue, and new bone formation, without clinical or routine histological signs of acute rejection. SPARC (Secreted protein acidic and rich in cysteine) expression supported osteogenic activity. Regenerated palates were stable and fracture-resistant, whereas controls showed incomplete repair and fractures. These findings suggest that BEMS may address limitations of conventional palatal reconstruction and support further investigation for human palatal bone regeneration.